3 recruiting, 1 not yet recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 3, Not yet recruiting 1 |
Follow DLBCL - Diffuse Large B Cell Lymphoma: new trials by email Literature Review of DLBCL - Diffuse Large B Cell Lymphoma trials Research Report on DLBCL - Diffuse Large B Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma SCTB35 injection, Rituxumab, Gemcitabine - DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | Sinocelltech Ltd. | 101 | 2026-06-04 | 2026-08-13 |
| A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping C-Pola-R-CHP+X, CR-CHOP - DLBCL - Diffuse Large B Cell Lymphoma, Double Expressor Lymphoma | Phase 3 | Not yet recruiting | Ruijin Hospital | 156 | 2026-03-31 | 2026-04-06 |
| Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma. Cisplatin (modified schedule), Cisplatin, Dexametasone - DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | King Edward Medical University | 74 | 2026-03-18 | 2026-08-10 |
| Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma Dexrazoxane, Rituximab, Cyclophosphamide - DLBCL - Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | Stichting Hemato-Oncologie voor Volwassenen Nederland | 324 | 2024-08-15 | 2026-09-23 |
Dendritic Cell Sarcoma, Interdigitating (4) · Cardiotoxicity (1) · Heart Failure (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (4) · Histiocytic Disorders, Malignant (4) · Histiocytosis (4) · Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1)
Absorptiometry, Photon (1) · Cisplatin (1) · Cyclophosphamide (1) · Cytarabine (1) · Dexrazoxane (1) · Doxorubicin (1) · Gemcitabine (1) · Lenalidomide (1) · Oxaliplatin (1) · Prednisolone (1) · Rituximab (1) · Vincristine (1) · pegfilgrastim (1)
King Edward Medical University (1) · Ruijin Hospital (1) · Sinocelltech Ltd. (1) · Stichting Hemato-Oncologie voor Volwassenen Nederland (1)
China (2) · Netherlands (1) · Pakistan (1)
A. van Rhenen, MD (1) · Inbsaat Iqbal, MBBS, MD (1)
2023 (1)